Gastrointestinal neuromuscular disease

Gene: MYL9

Green List (high evidence)

MYL9 (myosin light chain 9)
EnsemblGeneIds (GRCh38): ENSG00000101335
EnsemblGeneIds (GRCh37): ENSG00000101335
OMIM: 609905, Gene2Phenotype
MYL9 is in 3 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Green List (high evidence)

PMID:32621347; 3rd family with non-consanguineous parents and 3 TOPs.
Created: 20 Jan 2022, 10:27 p.m. | Last Modified: 20 Jan 2022, 10:27 p.m.
Panel Version: 1.15
Second unrelated family reported, bi-allelic LOF variants, promote to Amber.
Created: 24 Nov 2020, 9:55 a.m. | Last Modified: 24 Nov 2020, 9:55 a.m.
Panel Version: 0.30

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Megacystis-microcolon-intestinal hypoperistalsis syndrome, MIM#619365

Publications

Bryony Thompson (Royal Melbourne Hospital)

Red List (low evidence)

Single consanguineous family reported with a homozygous deletion including the last exon of the gene. No functional evidence.
Sources: Literature
Created: 3 Jul 2020, 6:03 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Megacystis-microcolon-intestinal hypoperistalsis syndrome

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Literature
Phenotypes
  • Megacystis-microcolon-intestinal hypoperistalsis syndrome, MIM#619365
OMIM
609905
Clinvar variants
Variants in MYL9
Penetrance
None
Publications
Panels with this gene

History Filter Activity

20 Jan 2022, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: MYL9 were set to 29453416; 33031641

20 Jan 2022, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: myl9 has been classified as Green List (High Evidence).

17 Jun 2021, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: MYL9 were changed from Megacystis-microcolon-intestinal hypoperistalsis syndrome to Megacystis-microcolon-intestinal hypoperistalsis syndrome, MIM#619365

24 Nov 2020, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: MYL9 were set to 29453416

24 Nov 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: myl9 has been classified as Amber List (Moderate Evidence).

3 Jul 2020, Gel status: 1

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: myl9 has been classified as Red List (Low Evidence).

3 Jul 2020, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Bryony Thompson (Royal Melbourne Hospital)

gene: MYL9 was added gene: MYL9 was added to Gastrointestinal neuromuscular disease. Sources: Literature Mode of inheritance for gene: MYL9 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: MYL9 were set to 29453416 Phenotypes for gene: MYL9 were set to Megacystis-microcolon-intestinal hypoperistalsis syndrome Review for gene: MYL9 was set to RED